0001225208-24-010179.txt : 20241125 0001225208-24-010179.hdr.sgml : 20241125 20241125174648 ACCESSION NUMBER: 0001225208-24-010179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241125 FILED AS OF DATE: 20241125 DATE AS OF CHANGE: 20241125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butcher Arthur C CENTRAL INDEX KEY: 0001678249 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 241497471 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0508 4 2024-11-25 0000885725 BOSTON SCIENTIFIC CORP BSX 0001678249 Butcher Arthur C 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP& Grp Pres, MedSurg & APAC 1 Common Stock 2024-11-25 4 M 0 3177.0000 22.7100 A 13979.0000 D Common Stock 2024-11-25 4 M 0 1009.0000 17.2600 A 14988.0000 D Common Stock 2024-11-25 4 S 0 14010.0000 89.2694 D 978.0000 D Common Stock 13373.0000 I By 401(k) Stock Option (Right to Buy) 17.2600 2024-11-25 4 M 0 1009.0000 0.0000 D 2026-02-22 Common Stock 1009.0000 4036.0000 D Stock Option (Right to Buy) 22.7100 2024-11-25 4 M 0 3177.0000 0.0000 D 2026-06-01 Common Stock 3177.0000 12706.0000 D The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 22, 2023. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $88.76 to $89.74 inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant. /s/ Susan Thompson, Attorney-in-Fact 2024-11-25